Evoke Pharma Inc (EVOK)
4.90
-0.06
(-1.21%)
USD |
NASDAQ |
Dec 24, 16:00
Evoke Pharma Free Cash Flow: -5.325M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| MEI Pharma Inc | -43.43M |
| Revance Therapeutics Inc | -194.91M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.8187M |
| Cash from Financing (Quarterly) | 2.980M |
| Free Cash Flow Per Share (Quarterly) | -0.5848 |
| Free Cash Flow to Equity (Quarterly) | -0.8187M |
| Free Cash Flow Yield | -114.4% |